Surgical therapy of recurrent vulvar cancer - 20/08/11
, Markus Schmidt, MD b, Eric Steiner, MD b, Paul-Georg Knapstein, MD b, Heinz Koelbl, MD b
Reprint requests: W. Weikel, MD, Head, Department of Obstetrics and Gynecology, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany.Abstract |
Objective |
The success of various surgical interventions in 201 cases with recurrent vulvar carcinoma was examined in the light of patients’ pretreatment, surgical therapy, plastic reconstruction, and postoperative disease course.
Study design |
A databank of standardized clinical data was analyzed using statistical procedures.
Results |
Therapy was selected on an individual basis according to tumor status. Recurrence at a site distant from the primary tumor, particularly in the inguinal region, indicated a markedly unfavorable prognosis. In contrast, tumors recurring locally did not exhibit any significant differences. Plastic surgery reconstruction led to improvements with respect to operability, wound healing, and survival.
Conclusion |
Individualized reconstructive surgery of the vulva leads to good results in patients with recurrent vulvar cancer. To an even greater extent than is the case for primary therapy, plastic surgery enlarges the spectrum of feasible surgical alternatives so that a more favorable oncological outcome and excellent cosmetic results may be expected.
Le texte complet de cet article est disponible en PDF.Key words : Recurrent vulvar cancer, Plastic surgery, Reconstruction
Plan
Vol 195 - N° 5
P. 1293-1302 - novembre 2006 Retour au numéro
Article précédent
- Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients
- Denis Querleu, Eric Leblanc, Géraldine Cartron, Fabrice Narducci, Gwenael Ferron, Pierre Martel
- Reproductive performance in infertile women with rectovaginal endometriosis: Is surgery worthwhile?
- Paolo Vercellini, Giuliana Pietropaolo, Olga De Giorgi, Raffaella Daguati, Roberta Pasin, Pier Giorgio Crosignani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?